Literature DB >> 15856719

Latent structure of depression in a community sample: a taxometric analysis.

Tim Slade1, Gavin Andrews.   

Abstract

BACKGROUND: The latent structure of depression was examined using taxometric analysis, a family of statistical procedures designed specifically to test whether a given construct is best conceptualized as a distinct category or a continuous dimension.
METHOD: Data were derived from the Australian National Survey of Mental Health and Well-Being, a large epidemiological survey that measured the prevalence of the major DSM-IV and ICD-10 mental disorders. Two taxometric procedures, maximum covariance (MAXCOV) and mean above minus below a cut (MAMBAC), were carried out on a sample of 1933 community volunteers. Simulated categorical and dimensional datasets aided in the interpretation of the research data.
RESULTS: The results of the taxometric analyses in the subsample who endorsed at least one symptom of depression were consistent with a dimensional latent structure of depression.
CONCLUSIONS: The findings of the current study suggest that depression, as measured in this subsample, is best conceptualized, measured and classified as a continuously distributed syndrome rather than as a discrete diagnostic entity. Incorporation of dimensional measurement into psychiatric classification systems remains a challenge for the future.

Entities:  

Mesh:

Year:  2005        PMID: 15856719     DOI: 10.1017/s0033291704003708

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  23 in total

1.  Evidence for the continuous latent structure of mania in the Epidemiologic Catchment Area from multiple latent structure and construct validation methodologies.

Authors:  J J Prisciandaro; J E Roberts
Journal:  Psychol Med       Date:  2010-05-27       Impact factor: 7.723

2.  Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Joseph F Goldberg
Journal:  J Abnorm Psychol       Date:  2012-05-28

Review 3.  Dimensionality and the category of major depressive episode.

Authors:  Gavin Andrews; Traolach Brugha; Michael E Thase; Farifteh Firoozmand Duffy; Paola Rucci; Timothy Slade
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

4.  A dimensional and categorical architecture for the classification of psychotic disorders.

Authors:  Victor Peralta; Manuel J Cuesta
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

Review 5.  The A, B, C's of factitious disorder: a response to Turner.

Authors:  James C Hamilton; Marc D Feldman; Jeffrey W Janata
Journal:  Medscape J Med       Date:  2009-01-27

6.  New insights into the correlation structure of DSM-IV depression symptoms in the general population v. subsamples of depressed individuals.

Authors:  S Foster; M Mohler-Kuo
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-09       Impact factor: 6.892

7.  Externalizing Outcomes of Youth with and without ADHD: Time-Varying Prediction by Parental ADHD and Mediated Effects.

Authors:  Elizabeth Moroney; Irene Tung; Whitney A Brammer; Tara S Peris; Steve S Lee
Journal:  J Abnorm Child Psychol       Date:  2017-04

8.  A load on my mind: evidence that anhedonic depression is like multi-tasking.

Authors:  Keith Bredemeier; Howard Berenbaum; James R Brockmole; Walter R Boot; Daniel J Simons; Steven B Most
Journal:  Acta Psychol (Amst)       Date:  2011-12-07

9.  Taxometric evidence of a dimensional latent structure for depression in an epidemiological sample of children and adolescents.

Authors:  R T Liu
Journal:  Psychol Med       Date:  2016-01-08       Impact factor: 7.723

10.  Gender differences in the impact of daily sadness on 24-h heart rate variability.

Authors:  Bart Verkuil; Jos F Brosschot; Andrea H Marques; Kevin Kampschroer; Esther M Sternberg; Julian F Thayer
Journal:  Psychophysiology       Date:  2015-09-04       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.